Results 201 to 210 of about 13,428 (249)

Bioactive Potential of Chitosan-Oleic Acid Nanoparticles Loaded with Lemon Peel Essential Oil for Topical Treatment of Vulvovaginal Candidiasis. [PDF]

Molecules
Ibrahim FM, Shalaby ES, Abdelhameed MF, El-Akad RH, Ahmed KA, Abdel-Aziz MS, El Habbasha ES, Rodrigues CV, Pintado M.   +8 more
europepmc   +1 more source

Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics. [PDF]

Front Pharmacol
Rustandi T, Yumassik AM, Ilahi FS, Alfian R, Prihandiwati E, Susanto Y, Susilo YH, Ulfah M, Faizatun F.   +8 more
europepmc   +1 more source

Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology. [PDF]

Oxf Open Immunol
Cheng KO, Montaño DE, Zelante T, Dietschmann A, Gresnigt MS.   +4 more
europepmc   +1 more source

Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis

, 2018
Fen Qin, Quan Wang, Chunlian Zhang, Fang Cai-yun, Liping Zhang, Hailin Chen, Mi Zhang, Fei Cheng   +7 more
openalex   +2 more sources

Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis

, 2018
И. О. Малова, Yu.A. Kuznetsova
openalex   +1 more source

Distribution and antifungal susceptibility of Candida species causing vulvovaginal candidiasis and urinary tract infection in Medlatec healthcare system, Ha Noi city, Vietnam in 2023. [PDF]

Ther Adv Infect Dis
Ngai PV, Dat TH, Nhi LY, Linh TTK, Thu NT, Anh VL, Dung BTT, Tran PV, Hien NT, Son NT, Que TT, Anh DN.   +11 more
europepmc   +1 more source

Current features of vulvovaginal candidiasis and selection of rational therapy in pregnant and nonpregnant women

, 2018
Т.Н. Бебнева, Г. Б. Дикке   +1 more
openalex   +1 more source

Antifungal susceptibility testing and determination of local epidemiological cut-off values for <i>Candida</i> species isolated from women with vulvovaginal candidiasis. [PDF]

Microbiol Spectr
Kroustali V, Kanioura L, Resoulai E, Siopi M, Antonopoulou S, Meletiadis J.   +5 more
europepmc   +1 more source

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection. [PDF]

Heliyon
Wang Y, Liu Z, Chen T.
europepmc   +1 more source

The impact of fluconazole use on the fungal and bacterial microbiomes in recurrent Vulvovaginal Candidiasis (RVVC): a pilot study of vaginal and gastrointestinal site interplay. [PDF]

Eur J Clin Microbiol Infect Dis
Bradfield Strydom M, Nelson TM, Khan S, Walpola RL, Ware RS, Tiralongo E.   +5 more
europepmc   +1 more source